[{"NetIncomeLoss_3_Q3_USD":-1124161000.0,"Depreciation_3_Q3_USD":23303000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-3081441000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q3_USD":4950000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-419000.0,"InventoryFinishedGoods_0_Q3_USD":34290000.0,"InterestPaidNet_3_Q3_USD":41577000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":279323000.0,"Depreciation_1_Q3_USD":8157000.0,"LiabilitiesNoncurrent_0_Q3_USD":624155000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_3_Q3_USD":-3585000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"RepaymentsOfLongTermDebt_3_Q3_USD":132061000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q3_USD":750000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":1148973077.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":1052940583.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q3_USD":-1393000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q3_USD":-1174000.0,"NetIncomeLossAttributableToNoncontrollingInterest_3_Q3_USD":-3713000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":2069610000.0,"ProceedsFromMinorityShareholders_3_Q3_USD":0.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":9099000.0,"Assets_0_Q3_USD":5566390000.0,"UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_0_Q3_USD":142858000.0,"CommonStockSharesIssued_0_Q3_shares":1182916659.0,"UnrecognizedTaxBenefits_0_Q3_USD":6542000.0,"IncomeTaxesPaidNet_3_Q3_USD":10596000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q3_USD":50297000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":0.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":47632000.0,"CostOfGoodsAndServicesSold_3_Q3_USD":49579000.0,"DueToRelatedPartiesNoncurrent_0_Q3_USD":0.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":160837000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":391967000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_3_Q3_USD":4879705000.0,"LongTermDebtCurrent_0_Q3_USD":50222000.0,"AssetsCurrent_0_Q3_USD":4965736000.0,"CostOfGoodsAndServicesSold_1_Q3_USD":21123000.0,"ProvisionForDoubtfulAccounts_3_Q3_USD":114000.0,"EquityMethodInvestments_0_Q3_USD":36756000.0,"PrepaidTaxes_0_Q3_USD":14192000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":23961000.0,"CommonStockValue_0_Q3_USD":118000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":-8423000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":-8344000.0,"AccountsReceivableNetCurrent_0_Q3_USD":60266000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":5711000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":29368000.0,"OtherSundryLiabilitiesNoncurrent_0_Q3_USD":170000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":4340000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q3_USD":750000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q3_USD":3128000.0,"InventoryRawMaterials_0_Q3_USD":1235000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":349070000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":939340000.0,"IncreaseDecreaseInOtherNoncurrentAssets_3_Q3_USD":5980000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":0.0,"MinorityInterest_0_Q3_USD":9020000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":4877168000.0,"CostsAndExpenses_3_Q3_USD":1381544000.0,"CostsAndExpenses_1_Q3_USD":531217000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-1044000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":184000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_3_Q3_USD":5312000.0,"Liabilities_0_Q3_USD":1269876000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":28679000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":1464470000.0,"ProceedsFromLongTermLinesOfCredit_3_Q3_USD":64288000.0,"OtherAssetsNoncurrent_0_Q3_USD":162600000.0,"AllowanceForDoubtfulAccountsReceivableRecoveries_3_Q3_USD":0.0,"AmortizationOfIntangibleAssets_1_Q3_USD":187000.0,"AmortizationOfIntangibleAssets_3_Q3_USD":658000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":21979000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-416344000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-1116579000.0,"IncreaseDecreaseInInventories_3_Q3_USD":6972000.0,"OtherPrepaidExpenseCurrent_0_Q3_USD":6888000.0,"RestrictedCash_0_Q3_USD":5245000.0,"UnrealizedGainLossOnInvestments_3_Q3_USD":9974000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q3_USD":-417518000.0,"ShareBasedCompensation_3_Q3_USD":134020000.0,"DeferredIncomeTaxAssetsNet_0_Q3_USD":48009000.0,"DeconsolidationGainOrLossAmount_3_Q3_USD":11307000.0,"InventoryWorkInProcess_0_Q3_USD":0.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_3_Q3_USD":1972608000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-951127000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q3_USD":10143000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3_Q3_USD":7526000.0,"ProceedsFromShortTermDebt_3_Q3_USD":48983000.0,"LiabilitiesCurrent_0_Q3_USD":645721000.0,"InterestIncomeExpenseNet_1_Q3_USD":-614000.0,"Goodwill_0_Q3_USD":109000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":1427000.0,"OtherOperatingActivitiesCashFlowStatement_3_Q3_USD":1144000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":61443000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q3_USD":750000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q3_USD":750000.0,"CommonStockSharesOutstanding_0_Q3_shares":1182916659.0,"InterestIncomeExpenseNet_3_Q3_USD":7184000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":-10497000.0,"ValueAddedTaxReceivableNoncurrent_0_Q3_USD":29413000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":1469715000.0,"NetIncomeLoss_1_Q3_USD":-425224000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":291218000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":30926000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q3_USD":11884000.0,"PrepaidInsurance_0_Q3_USD":3775000.0,"NumberOfOperatingSegments_3_Q3_segment":1.0,"FiniteLivedIntangibleAssetsNet_0_Q3_USD":5188000.0,"AccountsPayableCurrent_0_Q3_USD":146265000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q3_USD":1000.0,"AdditionalPaidInCapital_0_Q3_USD":7367799000.0,"InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_0_Q3_USD":28723000.0,"AccruedIncomeTaxesCurrent_0_Q3_USD":19815000.0,"LongTermDebtNoncurrent_0_Q3_USD":151551000.0,"DeferredIncomeTaxesAndTaxCredits_3_Q3_USD":-8762000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":75830000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":150880000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q3_USD":4296514000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":848940000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-3080004000.0,"TaxesPayableCurrent_0_Q3_USD":9244000.0,"IncomeTaxesReceivable_0_Q3_USD":8062000.0,"InventoryNet_0_Q3_USD":35525000.0,"IncreaseDecreaseInAccruedIncomeTaxesPayable_3_Q3_USD":-12272000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":3254300000.0,"IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_3_Q3_USD":115872000.0,"AllowanceForDoubtfulAccountsReceivable_0_Q3_USD":114000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q3_USD":-435040000.0,"IncomeTaxReceivable_0_Q3_USD":5586000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3_Q3_USD":-1136218000.0,"OperatingIncomeLoss_3_Q3_USD":-1172770000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":91080000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":208774000.0,"CommonStockSharesAuthorized_0_Q3_shares":9500000000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":52941000.0,"InterestReceivableCurrent_0_Q3_USD":5792000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"OperatingIncomeLoss_1_Q3_USD":-440137000.0,"FiniteLivedIntangibleAssetsGross_0_Q3_USD":8316000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":5566390000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":71255000.0,"CashDivestedFromDeconsolidation_3_Q3_USD":2025000.0,"AssetsNoncurrent_0_Q3_USD":600654000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":3252873000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":82819000.0,"StockholdersEquity_0_Q3_USD":4287494000.0,"AllowanceForDoubtfulAccountsReceivableWriteOffs_3_Q3_USD":0.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":47890000.0,"ProfitLoss_1_Q3_USD":-426617000.0,"ProfitLoss_3_Q3_USD":-1127874000.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.37,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-1.07,"RestrictedCashAndCashEquivalentsAtCarryingValue_0_Q3_USD":295000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q3_USD":188000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":13280000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":292090000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":50297000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":134020000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":88689000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3_Q3_USD":-1120164000.0,"Ticker":"BGNE","CIK":"1651308","name":"BEIGENE, LTD.","OfficialName":"BeiGene Ltd. American Depositary Shares","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"18163188203.0","Country":"Cayman Islands","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201105"}]